Protiofate
- Level
- Commodity
- Parent
- 51473100
- Below
- 0
- Links · KBLI
- 10
Definition
UNSPSC 51473106This classification denotes an antifungal agent with the molecular formula C12H16O6S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier FIP88CI9Y3, chemically known as 3,4-dihydroxy-2,5-thiophenedicarboxylic acid dipropyl ester but more generally known as protiofate, which bears U.S. NIH Compound Identifier 5464207. European Medicines Agency schedules Protiofate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10140MIG. The term PROTIOFATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules protiofate in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. PROTIOFATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.
Same parent
Under 51473100 · 6Activities that produce or sell this
KBLI · 10Inherited from family 51470000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.